Skip to main content
All lobbying filings

Thorn Run Partners

Thorn Run Partners filed a Q4 report for Otsuka America Pharmaceutical, Inc. on January 20, 2026, reporting $50,000 in lobbying income.

Lobbying for Otsuka America Pharmaceutical, Inc. · Pharmaceutical manufacturer.

As filed: THORN RUN PARTNERS for OTSUKA AMERICA PHARMACEUTICAL, INC.

All filings by Thorn Run Partners · Everything Otsuka America Pharmaceutical, Inc. has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
Maryland

Official filing document

 Lobbyists on this filing 1
  • BEAU SCHUYLER
    Previously held: Legislative Director, Rep. Tanner; Legislative Director, Rep. McIntyre

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3

Pharmaceutical reimbursement issues.

Issues related to neurological treatments.

Corporate tax issues.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem